Parin Enterprises Limited, formerly Parin Furniture Limited, is an India-based furniture manufacturing company that has established itself as a significant player in the institutional furniture segment. It has been associated with prestigious projects for furniture supply, including the Swarnim Gujarat Sports Foundation, Rashtriya Madhyamik Shiksha Abhiyan, Sarva Shiksha Abhiyan, Indian Institute of Technology (IIT) Guwahati, IIT Gandhinagar, and various medical colleges under the All India Institute Of Medical Science (AIIMS) umbrella. The company demonstrates its capability to serve varied customer requirements from institutional to residential markets through its diverse product portfolio.
The company provides a range of products across several categories:
- Institutional Furniture: Office furniture, educational furniture.
- Health Care Furniture: Isolation beds, fowler beds, motorized beds, support furniture.
- Non-Medical Furniture
- Home Furniture: Living room, dining room, and bedroom sets.
- Public Seating System: The company provides waiting area seating systems at airports in technical collaboration with C.C.M Srl Group, Italy, highlighting its commitment to global standards in specialized seating solutions.
Parin Enterprises Ltd. has a market capitalization of approximately ₹416 crore. The stock has shown significant volatility and growth potential, with a 52-week high and low on NSE recorded at ₹410.95 and ₹146.10 respectively. Over the past year, PARIN ENTERPRISES LIMITED has achieved a substantial return of 131.84%.
The company's valuation metrics include a PE ratio of 62.09 and a PB ratio of 6.04 (as of 06 Jun, 2025). These ratios suggest a premium valuation, indicating market confidence in the company's growth prospects.
- FY25 Audited Results:
- Revenue: ₹167.65 Crore (Rs 16765L)
- Profit: ₹6.9 Crore (Rs 690L)
- Strategic Acquisition: 51% stake in Umerin acquired.
- Trailing 12-Month (TTM) Performance:
- Operating Revenue: ₹323.24 Crore
- Pre-tax Margin: 4% (needs improvement)
- Return on Equity (ROE): 3% (fair, but needs improvement)
- Debt to Equity Ratio: 15% (reasonable, signaling a healthy balance sheet)
- Annual Revenue Growth: 0% (needs improvement)
Parin Enterprises operates within the furniture manufacturing sector, with a product portfolio spanning institutional, healthcare, home, and public seating systems. Its technical collaboration with Italy's C.C.M Srl Group for airport seating systems demonstrates its capacity to integrate international standards into its operations.
The company's market standing is also reflected in its performance ratings from an O'Neil Methodology perspective:
- EPS Rank: 26 (POOR, indicating inconsistency in earnings)
- RS Rating: 93 (GREAT, indicating outperformance compared to other stocks)
- Buyer Demand: B+ (evident from recent demand for the stock)
- Group Rank: 19 (belongs to a strong industry group: Retail-Home Furnishings)
- Master Score: B (close to being the best)
Parin Enterprises offers a diverse range of furniture products tailored for various market segments:
- Institutional: Office furniture, educational furniture for schools and universities.
- Healthcare: Specialized furniture like isolation beds, fowler beds, motorized beds, and support furniture for hospitals and medical facilities.
- Home Furniture: A comprehensive selection for living rooms, dining rooms, and bedrooms.
- Public Seating: Including airport waiting area seating systems developed through international collaboration.
Over the last 5 years, Parin Enterprises' revenue has grown at a yearly rate of 2.79%, which is lower than the industry average of 10.02%. During the same period, its market share has decreased from 8.72% to 3.89%, suggesting increased competition and the need for strategic initiatives.
However, the company's involvement in large-scale institutional projects, particularly with prestigious educational institutions like IITs and medical colleges under AIIMS, positions it well for India's ongoing infrastructure development. As the government continues to invest in educational and healthcare infrastructure, Parin Enterprises is poised to benefit from these opportunities.
From a technical standpoint, the stock is comfortably placed above its key moving averages (around 5% from 50DMA and 66% from 200DMA), suggesting positive momentum and technical strength.
The company maintains regular corporate governance practices. Key dates include:
- Board of Directors Meeting: Scheduled for November 14, 2024.
- 18th Annual General Meeting (AGM): Held on September 9, 2024.
These regular meetings underscore the company's commitment to transparent governance and stakeholder communication.
